SynAct Pharma AB (SYNACT.ST)

SEK 9.69

(0.36%)

Total Debt Summary of SynAct Pharma AB

  • SynAct Pharma AB's latest annual total debt in 2023 was 637 Thousand SEK , down -69.14% from previous year.
  • SynAct Pharma AB's latest quarterly total debt in 2024 Q3 was 498 Thousand SEK , down -0.63% from previous quarter.
  • SynAct Pharma AB reported annual total debt of 2.06 Million SEK in 2022, down -33.18% from previous year.
  • SynAct Pharma AB reported annual total debt of 3.08 Million SEK in 2021, down 0.0% from previous year.
  • SynAct Pharma AB reported quarterly total debt of 498 Thousand SEK for 2024 Q3, down -0.63% from previous quarter.
  • SynAct Pharma AB reported quarterly total debt of 498 Thousand SEK for 2024 Q1, down -21.82% from previous quarter.

Annual Total Debt Chart of SynAct Pharma AB (2023 - 2014)

Historical Annual Total Debt of SynAct Pharma AB (2023 - 2014)

Year Total Debt Total Debt Growth
2023 637 Thousand SEK -69.14%
2022 2.06 Million SEK -33.18%
2021 3.08 Million SEK 0.0%
2020 - SEK 0.0%
2019 - SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%
2014 - SEK 0.0%

Peer Total Debt Comparison of SynAct Pharma AB

Name Total Debt Total Debt Difference
Alligator Bioscience AB (publ) 16.09 Million SEK 96.043%
Ziccum AB (publ) 857 Thousand SEK 25.671%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 4.97 Million SEK 87.206%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 24.48 Million SEK 97.399%
Genovis AB (publ.) 79.32 Million SEK 99.197%
Intervacc AB (publ) 181 Thousand SEK -251.934%
QuiaPEG Pharmaceuticals Holding AB (publ) 20.61 Million SEK 96.909%
Active Biotech AB (publ) 3 Million SEK 78.767%
Magle Chemoswed Holding AB (publ) 60.3 Million SEK 98.944%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) 5 Million SEK 87.26%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 71.4 Million SEK 99.108%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 7.82 Million SEK 91.863%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -50.236%
Egetis Therapeutics AB (publ) 108.6 Million SEK 99.413%
Karolinska Development AB (publ) 3.07 Million SEK 79.251%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) 2.58 Million SEK 75.31%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK 36.3%
Calliditas Therapeutics AB (publ) 979.13 Million SEK 99.935%
Camurus AB (publ) 24.5 Million SEK 97.401%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 27.56 Million SEK 97.689%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 866.76 Million SEK 99.927%
Cyxone AB (publ) 858 Thousand SEK 25.758%
ExpreS2ion Biotech Holding AB (publ) 1.71 Million SEK 62.77%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 36.8 Million SEK 98.269%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 666 Thousand SEK 4.354%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK 25.059%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK 63.827%
BioInvent International AB (publ) 23.24 Million SEK 97.26%
Alzinova AB (publ) 800 Thousand SEK 20.375%
Oncopeptides AB (publ) 106.48 Million SEK 99.402%
Pila Pharma AB (publ) 773.08 Thousand SEK 17.602%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 99.298%
Diamyd Medical AB (publ) 30.67 Million SEK 97.923%
Xbrane Biopharma AB (publ) 231.47 Million SEK 99.725%
Ascelia Pharma AB (publ) 1.06 Million SEK 39.962%
Diagonal Bio AB (publ) - SEK -Infinity%